Innovative Medical ManagementLtd First Quarter 2024 Earnings: CN¥0.007 loss per share (vs CN¥0.005 loss in 1Q 2023)

Innovative Medical ManagementLtd (SZSE:002173) First Quarter 2024 Results

Key Financial Results

• Revenue: CN¥201.3m (down 1.4% from 1Q 2023).
• Net loss: CN¥2.98m (loss widened by 38% from 1Q 2023).
• CN¥0.007 loss per share (further deteriorated from CN¥0.005 loss in 1Q 2023).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Innovative Medical ManagementLtd shares are up 8.5% from a week ago.

Balance Sheet Analysis

Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We've done some analysis and you can see our take on Innovative Medical ManagementLtd's balance sheet.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.